Related Experiment Video
Updated: Jun 19, 2026

Injectable Supramolecular Polymer-Nanoparticle Hydrogels for Cell and Drug Delivery Applications
Published on: February 7, 2021
Moisture-responsive smart hydrogel for adaptive regulation of timolol delivery kinetics under variable wound exudate
Y Wiedemann1, S Pflumm2, S Ludwigs2
1Pharmaceutical Technology, Institute of Pharmacy and Biochemistry, University of Tuebingen, Auf der Morgenstelle 8, 72076 Tuebingen, Germany.
Abstract:
Effective wound therapy requires systems that respond to dynamic moisture conditions while enabling controlled drug delivery. This work focuses on the application of a previously developed programmable, humidity responsive hydrogel for exudate management in combination with targeted delivery of timolol, a β-adrenergic antagonist with emerging therapeutic relevance in wound healing. The influence of predefined hydrogel hydration and exudate levels on drug release and skin permeation across wounded and non-wounded skin was evaluated. The hydrated state of the hydrogel exhibited rapid diffusion-controlled drug release, whereas the conditioned hydrogel showed a biphasic swelling-controlled release behavior with initial polymer relaxation followed by predominantly diffusional transport. Higher exudate levels accelerated swelling and shifted the inflection point up to 2.7-fold earlier. Wounded skin showed rapid permeation, while non-wounded skin exhibited pronounced lag phases and up to 77-fold lower permeation. The steady-state flux across wounded skin from the conditioned hydrogel was 1.7-fold lower compared to the hydrated hydrogel. The hydrogel exhibits a fluid handling capacity comparable to superabsorbent dressings while maintaining high moisture vapor transmission. Combining timolol with this smart and self-adjusting material paves the way for a novel category of personalized wound therapy adaptable to a broad range of wound states.
Related Concept Videos
Ophthalmic Drug Delivery Systems
Modified-Release Drug Delivery Systems: Stimuli-Activated
Modified-Release Drug Delivery Systems: Rate-Programmed II
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Modified-Release Drug Delivery Systems: Classification